Posts With Tag Regulatory Approval

IceCure Medical Ltd. submits Form 6-K for SEC approval of XSense™ Cryoablation System in Israel. Key insights into innovation and growth opportunities.

HUTCHMED (China) Limited's SEC Form 6-K reveals full NMPA approval for ORPATHYS, enhancing market prospects for treating advanced NSCLC. Filed January 14, 2025.

Explore Rail Vision Ltd.'s latest Form 6-K report detailing their December 2024 developments, including Israel Railways' approval for MainLine products and its implications for investors.